Tadalafil and Sildenafil ( DrugBank: Sildenafil, Tadalafil )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
113	Muscular dystrophy	2

113. Muscular dystrophy

---

Clinical trials : 622 /  Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01580501 (ClinicalTrials.gov)	March 2012	17/4/2012	PDE Inhibitors in DMD Study (Acute Dosing Study)	Functional Muscle Ischemia and PDE5 Inhibition in Duchenne Muscular Dystrophy: Acute Dosing Study	Duchenne Muscular Dystrophy	Drug: Tadalafil and Sildenafil	Cedars-Sinai Medical Center	NULL	Completed	7 Years	15 Years	Male	12	Phase 1	United States
2	NCT01359670 (ClinicalTrials.gov)	May 2011	23/5/2011	Tadalafil and Sildenafil for Duchenne Muscular Dystrophy	Functional Muscle Ischemia and PDE5A Inhibition in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: Tadalafil;Drug: Sildenafil	Cedars-Sinai Medical Center	Parent Project Muscular Dystrophy	Completed	7 Years	15 Years	Male	30	Early Phase 1	United States